Sensorion SA (ALSEN)

Currency in EUR
0.3725
-0.0060(-1.59%)
Closed·

Sensorion SA Company Profile

Sensorion SA, a biotechnology company, engages in the development of novel therapies to restore, treat, and prevent hearing loss disorders in France. The company develops SENS-501, a dual AAV vector gene therapy development product for restoring hearing in patients with mutations in OTOF gene in Phase 1/2 clinical trials; and SENS-601, a candidate for the treatment of hearing loss caused by mutations of the GJB2 gene in preclinical studies. It is also developing SENS-40, a small molecule in Phase 2b clinical trials to treat sudden sensorineural hearing loss; prevention of residual hearing loss following cochlear implantation in Phase 2a clinical trials; and prevention of cisplatin-induced ototoxicity in Phase 2a clinical trials. The company was incorporated in 2009 and is headquartered in Montpellier, France.

Contact Information

Address
375, rue du Professeur Joseph Blayac, Montpellier, 34080, France

Top Executives

Name
Title
Since
Age
Amit D. MunshiChairman & Interim CEO202658
Eric Forquenot de La FortelleIndependent Director--
Christine PetitChair of Scientific Advisory Board2018-
Julien MiaraDirector201943
Khalil BarrageDirector202361
Cédric MoreauDirector201949
Hernán López-SchierMember of Scientific Advisory Board2020-
Paul AvanMember of Scientific Advisory Board2020-
Diane LazardMember of Scientific Advisory Board2020-
Robert J. DowMember of Scientific Advisory Board202075
Alain FischerMember of Scientific Advisory Board2020-
Aniz GirachIndependent Director202259
Natalie Brittenham BernerDirector202336
Florian Nicolas Christian ReinaudBoard Observer202353
Federico MingozziIndependent Director202452
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.